ENHANCED CORD BLOOD STEM CELL TRANSPLANTS SAFE IN LONG-TERM STUDIES
April 27, 2011
An innovative experimental treatment for boosting the effectiveness of stem-cell transplants with umbilical cord blood has a favorable safety profile in long-term animal studies, report scientists from Dana-Farber Cancer Institute, Beth Israel Deaconess Medical Center (BIDMC), and Children’s Hospital Boston (CHB). Â (Adult Stem Cell Research Network)
